MYMDMyMD Pharmaceuticals, Inc.

Nasdaq mymd.com


$ 2.23 $ -0.23 (-9.87 %)    

Wednesday, 15-May-2024 15:05:52 EDT
QQQ $ 452.83 $ 6.97 (1.56 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 529.09 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 2.1
$ 2.31
$ 0.00 x 0
$ 0.00 x 0
$ 2.23 - $ 2.33
$ 2.00 - $ 70.50
24,035
na
4.85M
$ 2.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-18-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-25-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-20-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 07-13-2018 03-31-2018 10-Q
26 04-03-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 04-11-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 03-30-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-18-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-23-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 mymd-pharmaceuticals-filing-from-late-monday-shows-co-entered-omnibus-waiver-and-amendment-agreement-with-required-holders-under-previously-announced-securities-purchase-agreement

As previously disclosed, on February 21, 2023, MyMD Pharmaceuticals, Inc. (the "Company") entered into a Securities Pur...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 mymd-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement-for-continued-listing

MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company...

 mymd-pharmaceuticals-announces-1-for-30-reverse-stock-split-to-maintain-nasdaq-listing

Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyM...

 why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

 mymd-pharmaceuticals-has-been-granted-canadian-patent-number-3013634-titled-methods-of-increasing-hair-growth-and-improving-hair-appearance

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3013634/summary.html 

 why-lumiradx-shares-are-trading-lower-by-20-here-are-20-stocks-moving-premarket

Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-ca...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION